Shanghai (China) facility
Our Shanghai team specializes in preclinical pharmaceutical development offering a variety of options for study and molecule types, as well as capacity to accommodate fast and flexible study starts. From biologics to Immunotoxicology & Immunology to IND-enabling, our global data approach ensures dependable delivery.